LBX2 and colorectal carcinoma: In conclusion, a novel DNA methylation marker LBX2 could be used as a simple, cost-effective, easy-to-implement, and reliable diagnostic method for LNM of CRC compared to traditional methods, it holds the potential to provide a better clinical diagnosis for the precise treatment of CRC.